AdvancePCS: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
 
(One intermediate revision by the same user not shown)
Line 42: Line 42:
[[Category:1999 establishments in the United States]]
[[Category:1999 establishments in the United States]]
{{pharmacology-stub}}
{{pharmacology-stub}}
{{No image}}
__NOINDEX__

Latest revision as of 03:14, 17 March 2025

AdvancePCS is one of the largest Pharmacy Benefit Management (PBM) companies in the United States. The company provides a wide range of services to manage prescription drug benefits on behalf of health insurers, self-insured employers, and government agencies.

History[edit]

AdvancePCS was formed in 1999 through the merger of PCS Health Systems and Advance Paradigm. The company was acquired by Caremark Rx in 2004, which later merged with CVS Health in 2007.

Services[edit]

AdvancePCS provides a variety of services to manage prescription drug benefits. These include:

  • Formulary Management: AdvancePCS develops and manages a list of preferred drugs, known as a formulary, for its clients. The formulary is designed to encourage the use of cost-effective drugs.
  • Claims Processing: AdvancePCS processes prescription drug claims on behalf of its clients. This includes verifying member eligibility, applying the appropriate copayment, and reimbursing the pharmacy.
  • Drug Utilization Review: The company reviews prescription drug use to identify potential issues, such as drug interactions or overuse.
  • Disease Management: AdvancePCS offers programs to help manage chronic conditions, such as diabetes or asthma. These programs provide education, medication reminders, and other support to help members manage their health.

Impact[edit]

As one of the largest PBMs in the U.S., AdvancePCS plays a significant role in the healthcare system. The company's services can help to control prescription drug costs, improve medication adherence, and enhance patient outcomes.

Criticism[edit]

Like other PBMs, AdvancePCS has faced criticism for its role in the high cost of prescription drugs. Critics argue that PBMs contribute to high drug prices by negotiating rebates from drug manufacturers, which are not always passed on to consumers.

See Also[edit]

References[edit]

<references group="" responsive="1"></references>

This article is a stub related to pharmacology. You can help WikiMD by expanding it!